Health Problems

Breakthrough for difficult-to-treat breast cancer

Chemists at Hong Kong Baptist University (HKBU) have discovered the use of a metal compound that inhibits the enzyme closely associated with triple-negative breast cancer (TNBC), one of the most difficult forms of breast cancer to treat. The metal compound is found to inhibit the TNBC tumours with less toxicity in mice, thus their work […]

Health Problems

Blood-borne cancer detection receives gold-plated boost

UNSW researchers have discovered a new way to detect ultralow levels of microRNA in a blood sample which could make diagnosis of cancer and other illnesses quicker and more efficient. The research team used nanoparticles to latch on to the targeted microRNAs (miRNAs) which enabled them to be easily extracted. One of the main benefits […]

Health Problems

Blood cancer patients benefit from breakthrough genetic testing service

Cutting-edge DNA sequencing technology has been used by QUT researchers at the new Australian Translational Genomics Centre (ATGC) to identify genetic mutations in 100 patients with blood cancers, with this testing providing clinically important information to doctors about prognosis and likely treatment responses for the majority of patients. Launched in July last year, the ATGC […]

Health Problems

Understanding drug resistance in ovarian cancer

Work just published in Cancer Research by Drs. Hugo Wurtele and Elliot Drobetsky (Maisonneuve-Rosemont Hospital Research Center- CIUSSS de l’Est-de-l’Île-de-Montréal and Université de Montréal) sheds new light on the origins of chemotherapy drug resistance in ovarian cancer. This discovery, made in collaboration with researchers at the Centre Hospitalier de l’Université de Montreal (CHUM), Université Laval […]

Health Problems

Time to stop cancer screenings: what do patients want to hear?

(HealthDay)—Older adults prefer explanations about stopping cancer screening that emphasize the shift to focus on other health issues, according to a research letter published in the August issue of JAMA Oncology. Nancy L. Schoenborn, M.D., M.H.S., from the Johns Hopkins University School of Medicine in Baltimore, and colleagues conducted a cross-sectional survey of 881 U.S. […]